2-(6-Bromo-1H-indol-3-yl)acetic acid, 95.0%, 10g

1-(3-Methoxy-4-methylphenyl)cyclopropane-1-carboxylic acid, 95%, 5g

2-(4,6-Dimethylpyrimidin-2-yl)acetonitrile, 97%, 100mg

1-(4-Methoxyphenyl)-5-methyl-1h-pyrrole-2-carbaldehyde, 98%, 1g

1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea, 97.0%, 250mg

Nicotinic Acid [Matrix for MALDI-TOF/MS]>99.5%(HPLC)(T)5g

(5R)-5-(1-Methylethyl)-3-morpholinone, 97%, 1g

7-Fluoro-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 1g

2-(1-(TERT-BUTOXYCARBONYL)-3-METHYLAZETIDIN-3-YL)ACETIC ACID, 95.0%, 1g

5-Bromo-1-chloro-2,3-difluorobenzene, 98.0%, 250mg

Boc-3-aminophenol, 95.0%, 500g

1H-Indole-2-carbonitrile, 95.0%, 10g

Ru(OAc)2[(R)-tolbinap]200mg